Pipeline - Krystal Biotech, Inc

Krystal leverages its proprietary platform to develop novel, redosable gene therapies for diseases with a high unmet medical need.

Krystal Pipeline

Near-term focus on three target tissues with additional pipeline expansion under investigation.

Jeune Aesthetics Pipeline

Jeune Aesthetics, a wholly-owned subsidiary of Krystal Biotech, uses the same platform to treat aesthetic skin conditions.

Not an actual patient

Get more information on Jeune Aesthetics, Inc.

Discovering, developing, and commercializing genetic medicines with purpose

Krystal Pipeline

Krystal Biotech Pipeline